Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

McGill University

$210,000.00

Exploring tumour-immune cell interactions using a bioprinted model of gastroesophageal cancer

EF 2024-25

Résumé
Gastroesophageal cancers are a significant health problem in North America, with a high death rate and poor survival outcomes. These cancers tend to spread quickly, and current treatments, such as chemotherapy and radiation, are only partially effective, as many patients do not respond. This highlights the need for new and more personalized treatment options. The goal of this research is to create a personalized tumour model in the lab using tissues from patients with gastroesophageal cancer. By combining cancer cells with immune cells, the model will mimic the complex environment found in actual tumours. This will help researchers study how the immune system interacts with the tumour and identify new treatment options. Using advanced techniques, the study will create 3D models of the tumour using a special gel that mimics the structure of human tissue. The models will then be used to study how the immune cells attack the tumour and how the tumour responds. The long-term goal is to use this model to test new treatments that could be tailored to individual patients, potentially improving survival rates and reducing the number of deaths caused by gastroesophageal cancer.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
513860
Name
Pillai Sangeeth
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Exploring tumour-immune cell interactions using a bioprinted model of gastroesophageal cancer
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$210,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
3d Culture; Bioengineered Tumours; Biomaterials; Bioprinting; Imaging Mass Cytometry; Immune Cell Therapy; Tissue Engineering; Transcriptomics
Abstract
Gastroesophageal cancers are a significant health problem in North America, with a high death rate and poor survival outcomes. These cancers tend to spread quickly, and current treatments, such as chemotherapy and radiation, are only partially effective, as many patients do not respond. This highlights the need for new and more personalized treatment options. The goal of this research is to create a personalized tumour model in the lab using tissues from patients with gastroesophageal cancer. By combining cancer cells with immune cells, the model will mimic the complex environment found in actual tumours. This will help researchers study how the immune system interacts with the tumour and identify new treatment options. Using advanced techniques, the study will create 3D models of the tumour using a special gel that mimics the structure of human tissue. The models will then be used to study how the immune cells attack the tumour and how the tumour responds. The long-term goal is to use this model to test new treatments that could be tailored to individual patients, potentially improving survival rates and reducing the number of deaths caused by gastroesophageal cancer.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Pillai, Sangeeth
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,000~ $0~